Skip to main content

Articles

Page 6 of 61

  1. Previous studies have reported an association between a significant decline in estimated glomerular filtration rate (eGFR) over time and an increased risk of cardiovascular disease (CVD). This study aimed to i...

    Authors: Azra Ramezankhani, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2023 22:270
    Content type: Research Published on:

  2. Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, ...

    Authors: Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, Martin Benedikt, Norbert J. Tripolt, Markus Wallner, Peter N. Pferschy, Friederike von Lewinski, Nora Schwegel, Rury R. Holman, Abderrahim Oulhaj, Deddo Moertl, Jolanta Siller-Matula and Harald Sourij
    Citation: Cardiovascular Diabetology 2023 22:269
    Content type: Research Published on:

  3. Previous studies have reported that inflammatory responses can promote the onset of cardiovascular diseases; however, its association with cardiac conduction disorders remains unclear. The present community-ba...

    Authors: Lili Wu, Meimei Wu, Dandan Zhao, Shuohua Chen, Guodong Wang, Lina Xu, Yujing Wang, Lina An, Shouling Wu, Congliang Miao and Jiang Hong
    Citation: Cardiovascular Diabetology 2023 22:268
    Content type: Research Published on:

  4. Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk ...

    Authors: Gaiying Dong, Man Gan, Shilin Xu, Yanlin Xie, Ming Zhou and Liangliang Wu
    Citation: Cardiovascular Diabetology 2023 22:267
    Content type: Research Published on:

  5. The impact of Type 2 Diabetes (T2D) on the outcomes of heart transplantation (HT) has not yet been clearly established. The objectives of this study were to examine the trends in the prevalence of T2D among in...

    Authors: Ana Lopez-de-Andres, Rodrigo Jiménez-García, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Ricardo Omaña Palanco, Jose L. del-Barrio, Javier de-Miguel-Díez, Jose M. de-Miguel-Yanes and Natividad Cuadrado-Corrales
    Citation: Cardiovascular Diabetology 2023 22:266
    Content type: Research Published on:

  6. Diabetes poses a significant threat to human health. There is a lack of large-scale cohort studies to explore the association between mortality risk and indicators beyond blood glucose monitoring in diabetic p...

    Authors: Fan Yang, Mingsi Wang, Yuzhu Chen, Jianjun Wu and Yilan Li
    Citation: Cardiovascular Diabetology 2023 22:265
    Content type: Research Published on:

  7. Frailty is an age-related geriatric syndrome that leads to a series of clinically negative events. A better understanding of the factors associated with frailty assists in preventing its progression. The trigl...

    Authors: Yin Yuan, Simiao Chen, Chunjin Lin, Xiaoming Huang, Siyang Lin, Feng Huang and Pengli Zhu
    Citation: Cardiovascular Diabetology 2023 22:264
    Content type: Research Published on:

  8. The impact of insulin resistance on the prognosis of heart failure with preserved ejection fraction (HFpEF) remains unknown. This study aimed to investigate the association between the triglyceride-glucose (Ty...

    Authors: Qing Zhou, Jie Yang, Hongyi Tang, Zexuan Guo, Wenyue Dong, Yiting Wang, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Xinwei Hua and Yi-Da Tang
    Citation: Cardiovascular Diabetology 2023 22:263
    Content type: Research Published on:

  9. Several large observational prospective studies have reported a protection by the traditional Mediterranean diet against type 2 diabetes, but none of them used yearly repeated measures of dietary intake. Repea...

    Authors: Miguel A. Martínez-González, Pedro Montero, Miguel Ruiz-Canela, Estefanía Toledo, Ramón Estruch, Enrique Gómez-Gracia, Jun Li, Emilio Ros, Fernando Arós, Alvaro Hernáez, Dolores Corella, Miquel Fiol, José Lapetra, Lluis Serra-Majem, Xavier Pintó, Montse Cofán…
    Citation: Cardiovascular Diabetology 2023 22:262
    Content type: Research Published on:

  10. Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in the coronary and caro...

    Authors: Carl Johan Östgren, Julia Otten, Karin Festin, Oskar Angerås, Göran Bergström, Kerstin Cederlund, Gunnar Engström, Maria J. Eriksson, Mats Eriksson, Tove Fall, Anders Gummesson, Emil Hagström, Urban Hellman, Stefan K. James, Tomas Jernberg, Johan Kihlberg…
    Citation: Cardiovascular Diabetology 2023 22:261
    Content type: Research Published on:

  11. Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and pathological functions by post-transcriptional regulation of gene expression being considered markers for many disea...

    Authors: Miruna Nemecz, Diana Simona Stefan, Ioana Karla Comarița, Alina Constantin, Gabriela Tanko, Cristian Guja and Adriana Georgescu
    Citation: Cardiovascular Diabetology 2023 22:260
    Content type: Research Published on:

  13. The relationship of cumulative remnant-cholesterol (Cum-RC) concentration with the risk of cardiovascular disease (CVD) in patients with hypertension remains unclear.

    Authors: Weiqiang Wu, Guanzhi Chen, Kuangyi Wu, Huancong Zheng, Yanjuan Chen, Xianxuan Wang, Zegui Huang, Zefeng Cai, Zhiwei Cai, Zhichao Chen, Yulong Lan, Shuohua Chen, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:258
    Content type: Research Published on:

  15. Diabetic peripheral neuropathy (DPN) has been shown to be independently associated with cardiovascular events and mortality. This study aimed to evaluate changes in left ventricular (LV) microvascular perfusio...

    Authors: Xue-Ming Li, Rui Shi, Meng-Ting Shen, Wei-Feng Yan, Li Jiang, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:256
    Content type: Research Published on:

  16. The Atherogenic Index of Plasma (AIP) is a newly identified biomarker associated with lipid metabolism, demonstrating significant prognostic capabilities in individuals diagnosed with cardiovascular disease. H...

    Authors: Jiasuer Alifu, Lanqing Xiang, Wen Zhang, Penglong Qi, Huiying Chen, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Xian Lv, Tingting Shi, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:255
    Content type: Research Published on:

  17. Stroke was reported to be highly correlated with the triglyceride glucose-body mass index (TyG-BMI). Nevertheless, literature exploring the association between changes in the TyG-BMI and stroke incidence is sc...

    Authors: Rong-Rui Huo, Lu Zhai, Qian Liao and Xue-Mei You
    Citation: Cardiovascular Diabetology 2023 22:254
    Content type: Research Published on:

  18. Whether recent reductions in cardiovascular disease (CVD) events and mortality in type 2 diabetes apply equally to both sexes is largely unknown. The aim of this study was to characterize temporal changes in C...

    Authors: Wendy A. Davis and Timothy M. E. Davis
    Citation: Cardiovascular Diabetology 2023 22:253
    Content type: Research Published on:

  19. A healthy lifestyle (HL) has been inversely related to type 2 diabetes (T2D) and cardiovascular disease (CVD). However, few studies have identified a metabolite profile associated with HL. The present study ai...

    Authors: Santiago Rios, Jesús F. García-Gavilán, Nancy Babio, Indira Paz-Graniel, Miguel Ruiz-Canela, Liming Liang, Clary B Clish, Estefania Toledo, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, Marta Guasch-Ferré, José M Santos-Lozano…
    Citation: Cardiovascular Diabetology 2023 22:252
    Content type: Research Published on:

  20. Insulin resistance (IR) is a pathophysiologic hallmark of type 2 diabetes and associated with the presence of chronic kidney disease (CKD). Experimental studies suggest that endothelin-1 increases IR. We asses...

    Authors: J. David Smeijer, Donald E. Kohan, Peter Rossing, Ricardo Correa-Rotter, Adrian Liew, Sydney C.W. Tang, Dick de Zeeuw, Ron T. Gansevoort, Wenjun Ju and Hiddo J. Lambers Heerspink
    Citation: Cardiovascular Diabetology 2023 22:251
    Content type: Research Published on:

  21. Authors: You Zhou, Chi Wang, Hebin Che, Liting Cheng, Di Zhu, Chongyou Rao, Qin Zhong, Zongren Li, Xiao Wang, Zisheng Wu and Kunlun He
    Citation: Cardiovascular Diabetology 2023 22:250
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2023 22:171

  22. Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those diseases. Using proton nuclear magnetic resonance (1H-NMR), we aimed to study the plasma ...

    Authors: Juan Moreno-Vedia, Dídac Llop, Ricardo Rodríguez-Calvo, Núria Plana, Núria Amigó, Roser Rosales, Yaiza Esteban, Josefa Girona, Lluís Masana and Daiana Ibarretxe
    Citation: Cardiovascular Diabetology 2023 22:249
    Content type: Research Published on:

  23. Type 2 diabetes mellitus (T2DM) is a major global health issue and a significant risk factor for atherosclerosis. Atherosclerosis in T2DM patients has been associated with inflammation, insulin resistance, hyp...

    Authors: Louise Ménégaut, Aline Laubriet, Valentin Crespy, Damien Leleu, Thomas Pilot, Kevin Van Dongen, Jean-Paul Pais de Barros, Thomas Gautier, Jean-Michel Petit, Charles Thomas, Maxime Nguyen, Eric Steinmetz and David Masson
    Citation: Cardiovascular Diabetology 2023 22:248
    Content type: Research Published on:

  24. MicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel bi...

    Authors: Mehrdad Samadishadlou, Reza Rahbarghazi, Zeynab Piryaei, Mahdad Esmaeili, Çığır Biray Avcı, Farhad Bani and Kaveh Kavousi
    Citation: Cardiovascular Diabetology 2023 22:247
    Content type: Research Published on:

  26. Diabetes mellitus (DM) is associated with thrombogenicity, clinically manifested with atherothrombotic events after percutaneous cutaneous intervention (PCI). This study aimed to investigate association betwee...

    Authors: Ki-Hyun Jeon, Young-Hoon Jeong, In-Ho Chae, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin…
    Citation: Cardiovascular Diabetology 2023 22:245
    Content type: Research Published on:

  27. Insulin resistance (IR) is a major metabolic disorder observed in heart failure (HF) and is tightly associated with patients’ poor prognosis. The triglyceride-glucose index (TyG) has been proposed as a surroga...

    Authors: Amirmohammad Khalaji, Amir Hossein Behnoush, Shaghayegh Khanmohammadi, Kimiya Ghanbari Mardasi, Sourena Sharifkashani, Amirhossein Sahebkar, Caterina Vinciguerra and Alessandro Cannavo
    Citation: Cardiovascular Diabetology 2023 22:244
    Content type: Research Published on:

  28. Endogenous estrogen is cardio-protective in healthy premenopausal women. Despite this favorable action of estrogen, animal models depict a detrimental effect of estradiol on vascular function in the presence o...

    Authors: Abigayle B. Simon, Cassandra C. Derella, Marsha Blackburn, Jeffrey Thomas, Lawrence C. Layman, Matthew S. Nicholson, Jennifer Waller, Ahmed Elmarakby, Karim M. Saad and Ryan A. Harris
    Citation: Cardiovascular Diabetology 2023 22:243
    Content type: Research Published on:

  31. To assess how inaccurately the body mass index (BMI) is used to diagnose obesity compared to body fat percentage (BF%) measurement and to compare the cardiometabolic risk in children and adolescents with or wi...

    Authors: J. Karina Zapata, M. Cristina Azcona-Sanjulian, Victoria Catalán, Beatriz Ramírez, Camilo Silva, Amaia Rodríguez, Javier Escalada, Gema Frühbeck and Javier Gómez-Ambrosi
    Citation: Cardiovascular Diabetology 2023 22:240
    Content type: Research Published on:

  32. High triglyceride-glucose index (TyG) is a major risk factor for heart failure, but the long-term effect of high TyG index on the risk of developing heart failure remains unclear. Therefore, we aimed to determ...

    Authors: Huancong Zheng, Guanzhi Chen, Kuangyi Wu, Weiqiang Wu, Zegui Huang, Xianxuan Wang, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:239
    Content type: Research Published on:

  33. The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance (IR). However, whether the TyG index has prognostic value in patients with moderate to severe aortic stenosis (AS) rema...

    Authors: Rihua Huang, Xinghao Xu, Chaoguang Xu, Shaozhao Zhang, Zhenyu Xiong, Menghui Liu, Yiquan Huang, Han Wen, Yue Guo, Xinxue Liao and Xiaodong Zhuang
    Citation: Cardiovascular Diabetology 2023 22:238
    Content type: Research Published on:

  34. Diabetes mellitus is a metabolic disease characterized by long-term hyperglycaemia, which leads to microangiopathy and macroangiopathy and ultimately increases the mortality of diabetic patients. Endothelial d...

    Authors: Ying An, Bu-tuo Xu, Sheng-rong Wan, Xiu-mei Ma, Yang Long, Yong Xu and Zong-zhe Jiang
    Citation: Cardiovascular Diabetology 2023 22:237
    Content type: Review Published on:

  35. The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unc...

    Authors: Zirui Liu, Haocheng Wang, Zhengkai Yang, Yu Lu and Cao Zou
    Citation: Cardiovascular Diabetology 2023 22:236
    Content type: Research Published on:

  36. Randomized controlled trials (RCTs) reported contrasting results about reverse left ventricular remodeling (LVR) after sodium-glucose co-transporter-2 inhibitors (SGLT2i) therapy in patients with heart failure...

    Authors: Erberto Carluccio, Paolo Biagioli, Gianpaolo Reboldi, Anna Mengoni, Rosanna Lauciello, Cinzia Zuchi, Sandra D’Addario, Giuliana Bardelli and Giuseppe Ambrosio
    Citation: Cardiovascular Diabetology 2023 22:235
    Content type: Research Published on:

  37. Microvascular dysfunction plays a crucial role in complications of type 2 diabetes and might contribute to heart failure with preserved ejection fraction (HFpEF), a disease that disproportionally affects women...

    Authors: Elisa Dal Canto, L. van Deursen, A. G. Hoek, P. J. M. Elders, H. M. den Ruijter, J. van der Velden, V. van Empel, E. H. Serné, E. C. Eringa and J. W.J. Beulens
    Citation: Cardiovascular Diabetology 2023 22:234
    Content type: Research Published on:

  38. Studies that have reported lower risk for cardiovascular outcomes in users of Sodium–Glucose Cotransporter-2 Inhibitors (SGLT-2i) are limited by residual cofounding and lack of information on prior cardiovascu...

    Authors: Dorte Vistisen, Bendix Carstensen, Patorno Elisabetta, Stefanie Lanzinger, Elise Chia-Hui Tan, Daisuke Yabe, Dae Jung Kim, Wayne H.-H. Sheu, Cheli Melzer-Cohen, Reinhard W. Holl, Júlio Núñez, Kyoung Hwa Ha, Sigrun Halvorsen, Gisle Langslet, Avraham Karasik, Thomas Nyström…
    Citation: Cardiovascular Diabetology 2023 22:233
    Content type: Research Published on:

  39. Insulin resistance (IR) can be effectively assessed using the dependable surrogate biomarker triglyceride-glucose (TyG) index. In various critical care contexts, like contrast-induced acute kidney injury (AKI)...

    Authors: Zewen Yang, Hongxia Gong, Fuqiang Kan and Ningning Ji
    Citation: Cardiovascular Diabetology 2023 22:232
    Content type: Research Published on:

  40. Adipokines are hormones secreted from adipose tissue and are associated with cardiometabolic diseases (CMD). Functional differences between adipokines (leptin, adiponectin, and resistin) are known, but inconsi...

    Authors: Daeeun Kim, Aylin Memili, Hung-Hsin Chen, Heather M. Highland, Hannah G. Polikowsky, Mohammad Yaser Anwar, Susan T. Laing, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher-Hoch, Jennifer E. Below, Kari E. North and Absalon D. Gutierrez
    Citation: Cardiovascular Diabetology 2023 22:231
    Content type: Research Published on:

  41. The triglyceride-glucose (TyG) index has been evaluated as a reliable surrogate for insulin resistance (IR) and has been proven to be a predictor of poor outcomes in patients with cardiovascular diseases. Howe...

    Authors: Zhenguo Wu, Lin Xie, Dachuan Guo, Sha Chen, Xiaoyu Liu, Xiangfei Sun, Juan Wang, Yerui Zhang, Li Liu, Huiliang Cui, Dejin Zang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2023 22:230
    Content type: Research Published on:

  43. Today, diabetes mellitus (DM) has become a worldwide concern. DM is a major risk factor for the development of cardiovascular diseases (CVD). Eligible patients with CVD are treated invasively by percutaneous c...

    Authors: Hong Wang, Quannan Zu, Hairong Tang, Ming Lu, Rongfa Chen and Zhiren Yang
    Citation: Cardiovascular Diabetology 2023 22:228
    Content type: Review Published on:

  44. Outcomes of diabetes screening in contemporary, multi-ethnic populations are unknown. We examined the association of prior outpatient diabetes screening with the risks of cardiovascular events and mortality in...

    Authors: Calvin Ke, Anna Chu, Baiju R. Shah, Sheldon Tobe, Karen Tu, Jiming Fang, Haris Vaid, Peter Liu, Aishah Cader and Douglas S. Lee
    Citation: Cardiovascular Diabetology 2023 22:227
    Content type: Research Published on:

  45. The global prevalence of metabolic syndrome and its association with increased morbidity and mortality has been rigorously studied. However, the true prevalence of “metabolic health”, i.e. individuals without ...

    Authors: Hadas Ben-Assayag, Rafael Y. Brzezinski, Shlomo Berliner, David Zeltser, Itzhak Shapira, Ori Rogowski, Sharon Toker, Roy Eldor and Shani Shenhar-Tsarfaty
    Citation: Cardiovascular Diabetology 2023 22:226
    Content type: Research Published on:

  46. Estimated glucose disposal rate (eGDR), a simple and noninvasive measure of insulin resistance, has been proven to be an independent risk factor for first-time stroke and all-cause mortality. In this study, we...

    Authors: Zhengzhao Lu, Yunyun Xiong, Xueyan Feng, Kaixuan Yang, Hongqiu Gu, Xingquan Zhao, Xia Meng and Yongjun Wang
    Citation: Cardiovascular Diabetology 2023 22:225
    Content type: Research Published on:

  47. High-sensitivity C-reaction protein (hsCRP), a biomarker of residual inflammatory risk, has been demonstrated with poor cardiovascular outcomes. We aimed to investigate the prognostic value of hsCRP in patient...

    Authors: Le Li, Shangyu Liu, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao
    Citation: Cardiovascular Diabetology 2023 22:223
    Content type: Research Published on:

  48. Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperativ...

    Authors: Etienne Chazal, Lucas Morin, Sidney Chocron, Philippe Lassalle, Sebastien Pili-Floury, Lucie Salomon du Mont, David Ferreira, Emmanuel Samain, Andrea Perrotti and Guillaume Besch
    Citation: Cardiovascular Diabetology 2023 22:221
    Content type: Research Published on:

  49. Semaglutide is a glucose-lowering treatment for type 2 diabetes (T2D) with demonstrated cardiovascular benefits; semaglutide may also have kidney-protective effects. This post hoc analysis investigated the associ...

    Authors: Peter Rossing, Stephen C. Bain, Heidrun Bosch-Traberg, Ekaterina Sokareva, Hiddo J. L. Heerspink, Søren Rasmussen and Linda G. Mellbin
    Citation: Cardiovascular Diabetology 2023 22:220
    Content type: Research Published on:

  50. Clinical observations suggest a complex relationship between obesity and coronary artery disease (CAD). This study aimed to characterize the intermediate metabolism phenotypes among obese patients with CAD and...

    Authors: Chong-Yu Zhang, Ru-Qin Xu, Xiao-Qiao Wang, Lin-Feng Sun, Pei Mo, Ren-Jie Cai, Xiao-Zhen Lin, Cheng-Feng Luo, Wen-Chao Ou, Lie-Jing Lu, Yun Zhong and Jia-Yuan Chen
    Citation: Cardiovascular Diabetology 2023 22:219
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840